Revumenib: Indication, Dosage, Side Effect

Indication:

REVUMENIB, of chorea associated with Huntington’s disease and for the treatment of relapsed or refractory acute leukemia in adult and pediatric patients aged 1 year and older who have a documented rearrangement of the KMT2A gene (also called KMT2A-translocation). More recently, the indication was expanded to include patients with relapsed or refractory acute myeloid leukemia (AML) harboring a susceptible NPM1 mutation who have no satisfactory alternative treatment options. This targeted therapy is specifically for those whose leukemia has this genetic marker (KMT2A rearrangement or NPM1 mutation) and who have already tried other treatments that failed or stopped being effective.

Dosage:

The recommended dosage for Revumenib (brand name Revuforj) for adults and children aged 1 year or older with relapsed or refractory acute leukemia harboring a KMT2A rearrangement (and in some cases an NPM1 mutation) is twice daily (every 12 hours) until disease progression or unacceptable toxicity. For patients weighing 40 kg or more, the dose is 270 mg orally twice a day (without strong CYP3A4 inhibitors) and reduced to 160 mg twice a day if a strong CYP3A4 inhibitor is concurrently used. For patients weighing less than 40 kg, the dose is body surface area (BSA)-based: without strong CYP3A4 inhibitors it is 160 mg/m² twice daily, and with strong CYP3A4 inhibitors it is reduced to 95 mg/m² twice daily; for example a BSA of 1 m² corresponds to ~160 mg twice daily in the first scenario.

Extra note:
Prior to starting Revumenib, the white blood cell count should be reduced to < 25 × 10⁹/L and an ECG should be performed because of the risk of QT-interval prolongation, and patients must be selected based on documented KMT2A rearrangement (or in the NPM1 case, a susceptible mutation). The drug may be held or dose-reduced for severe adverse effects (e.g., severe neutropenia or QT-prolongation) and should be continued for at least 6 months in responding patients (without progression/toxicity) to allow time for clinical benefit.

Note:

Revumenib is contraindicated in patients with untreated or active depression, suicidal ideation, hepatic impairment, or those taking monoamine oxidase inhibitors or reserpine. Regular monitoring of mood, motor symptoms, and cardiac status is recommended during therapy.

Side Effect:

The most common side effects of Revumenib are:   

Bleeding, Nausea and vomiting, Muscle or joint pain, Infection, Febrile neutropenia, Diarrhea or constipation, Loss of appetite, Fluid retention, Tiredness. Tell your doctor or pharmacist right away if any of these side effects persist or worsen.

Remember that your doctor has prescribed this medication because your doctor has judged that the benefit to you is greater than the risk of side effects. Many people using this medication do not have serious side effects.

Tell your health care provider about all of your health conditions and any prescription or over-the-counter (OTC) medicines, vitamins/minerals, herbal products, and other supplements you are using. This will help them determine if Revuforj is right for you.

Take this medication regularly to get the most benefit from it. To help you remember, take it at the same times on the days your doctor directs.

This is not a complete list of possible side effects. Contact your doctor or pharmacist if you have any other side effects not listed above.

FAQ:

Frequently Asked Questions Regarding (REVUMENIB) / Generic REVUFORJ REVUMENIB:

May I inquire about the availability of the generic form of REVUMENIB, commonly referred to as/ REVUFORJ, for global distribution?

Certainly! We are able to distribute (REVUMENIB) globally, thanks to WTO regulations and our patient support program, which is specifically designed for individual patient treatments.

What’s the minimum order quantity for the generic version of REVUMENIB?

The smallest amount you can order of (REVUMENIB) depends on what the client or patient needs.

How much does the generic REVUMENIB, sold as or REVUFORJ in various countries, cost?

The price of (REVUMENIB) will be shared once we get a valid order from clients or patients.

How is it possible to procure (REVUMENIB), the generic version of REVUFORJ?

Kindly complete our order form for the purchase of (REVUMENIB).

How can I confirm I'm receiving authentic (REVUMENIB) or generic REVUFORJ?

We’re a licensed online pharmacy specializing in global generic prescription medication distribution. We directly work with manufacturers or authorized agents to ensure authentic (REVUMENIB) from us. Verify authenticity through the manufacturer’s security code. Contact us for any concerns or questions.

Will I get/ REVUFORJ Generic REVUMENIB without any complications?

Elifesaving Medicine, a globally recognized company, provides essential prescription medicines. We excel in online medicine delivery and assist patients in obtaining valid prescriptions and relevant documents. We offer consultation and facilitation for patients, hospitals, clinicians, and researchers, helping them access trustworthy sources, especially those unavailable or unapproved in their countries. Registered doctors and patients recommend us. Many clients provide feedback and referrals. We ensure smooth delivery of (REVUMENIB). Contact us immediately for any issues or doubts.

How can I pay for my preferred medicine?

To proceed with your order, please make an advance payment using your preferred method (Bank transfer, Credit card, Alipay, Western Union, MoneyGram, etc.). Once we confirm your payment, we'll process your order immediately.

REVUMENIB has different brand names depending on the manufacturer. Some of the brand names are: